Quanome Technologies, Inc. (QNME) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2026, filed Sep 25, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the QNME SEC filings page.
Quanome Technologies, Inc. (QNME) reported $5.9M in revenue for fiscal year 2026, up 111.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue recovered in FY2026, but costs expanded faster, leaving a business that converts little of its gross profit into operating cash.
In FY2026, revenue more than doubled from FY2025 whilegross margin stayed near57% , yet SG&A more than doubled and operating loss widened to$10.2M ; this identifies spending growth, rather than gross-margin weakness, as the main operating drag. The accounting loss of$9.5M was roughly three times operating cash flow of-$3.2M , so reported earnings were materially worse than near-term cash movement, although cash conversion remained negative.
Short-term balance-sheet coverage improved: the current ratio rose from 1.1x to 2.5x as current liabilities fell, indicating more current-asset coverage. Yet the reported liquidity comparison was only 2.5 months of annual outflow, so balance-sheet coverage and cash availability tell different stories.
Free cash flow nearly matched operating cash flow while capital spending was only
Financial Health Signals
Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Quanome Technologies, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Quanome Technologies, Inc. held $670K in cash, cash equivalents and investments at the end of fiscal year 2026, and its operations used $3.2M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Quanome Technologies, Inc. scores 11/100 among other emerging companies.
Quanome Technologies, Inc. had 34M shares outstanding at the end of fiscal year 2026. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Quanome Technologies, Inc. scores 10/100 among other emerging companies.
Not available for Quanome Technologies, Inc., and counted as zero in the overall score.
Quanome Technologies, Inc. reported revenue of $5.9M in fiscal year 2026, against $2.8M in fiscal year 2025. Revenue Progress ranks emerging companies on the three-year path of that line, and Quanome Technologies, Inc. scores 7/100 among other emerging companies.
Quanome Technologies, Inc.'s operations used $3.2M of cash in fiscal year 2026, against $2.7M used in fiscal year 2025. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Quanome Technologies, Inc. scores 1/100 among other emerging companies.
Quanome Technologies, Inc.'s cash, cash equivalents and investments came to $670K at the end of fiscal year 2026, against $4.6M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Quanome Technologies, Inc. scores 22/100 among other emerging companies.
Quanome Technologies, Inc. scores -1.17, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($18.0M) relative to total liabilities ($4.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Quanome Technologies, Inc. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Quanome Technologies, Inc. reported a net loss of $9.5M while operations used $3.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Quanome Technologies, Inc. reported an operating loss of $10.2M against $150K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Quanome Technologies, Inc. earned -$0.24 per diluted share (EPS) in Q4 2026. Against the prior quarter it is down 2500.0%.
Not reported for Q4 2026.
Not reported for Q4 2026.
Not reported for Q4 2026.
Cash & Balance Sheet
Quanome Technologies, Inc. held $670K in cash as of Q4 2026; long-term debt is not reported for that period.
Not reported for Q4 2026.
Not reported for Q4 2026.
Margins & Returns
None of these metrics is reported for Q4 2026.
Capital Allocation
None of these metrics is reported for Q4 2026.
QNME Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $1.3M+167.0% | $7.0M+95.0% | $6.1M+49.5% | $9.6M+100.8% | $497K-88.9% | $3.6M-26.9% | $4.1M-1.6% |
| Cost of Revenue | N/A | $348K+192.2% | $5.1M+40.3% | $5.0M+40.2% | $7.6M+101.9% | $119K-96.6% | $3.6M-5.6% | $3.6M+1.7% |
| Gross Profit | N/A | $980K+159.1% | $1.9M+4623.4% | $1.1M+112.2% | $2.0M+96.4% | $378K-61.2% | -$42K-104.0% | $523K-19.3% |
| SG&A Expenses | N/A | $1.7M+181.1% | $2.2M+15.6% | $2.1M+14.7% | $3.1M+129.1% | $604K-37.2% | $1.9M+94.1% | $1.8M+114.7% |
| Operating Income | N/A | -$1.6M-378.3% | -$1.5M+25.4% | -$1.3M+4.2% | -$1.3M-314.1% | -$330K-914.1% | -$2.0M-2536.6% | -$1.3M-298.0% |
| EBITDA | N/A | -$1.5M-442.3% | -$1.4M+26.8% | -$1.2M+6.6% | -$1.2M-322.6% | -$284K-522.7% | -$2.0M-1928.4% | -$1.3M-322.5% |
| Interest Expense | N/A | $27K-34.1% | $34K-16.3% | $196K+598.8% | $29K+141.9% | $41K+58.8% | $41K+31.5% | $28K+23.4% |
| Income Tax | N/A | $30K+59.2% | $45K | $36K-59.8% | N/A | $19K-82.2% | N/A | $90K+4450.7% |
| Net Income | N/A | $142K+113.3% | -$1.6M+18.7% | -$1.4M-1.6% | -$893K-44401.2% | -$1.1M-8486.6% | -$1.9M-3131.3% | -$1.3M-338.9% |
| EPS (Basic) | -$0.24-118.2% | $0.01+107.1% | -$0.08+69.2% | -$0.09+50.0% | -$0.11 | -$0.14 | -$0.26-2700.0% | -$0.18-260.0% |
| EPS (Diluted) | -$0.24 | $0.01 | -$0.08 | -$0.09 | -$0.11 | -$0.14 | -$0.26-2700.0% | -$0.18-260.0% |
| Diluted Shares (Avg) | N/A | 34M | 20M | 15M | N/A | 8M+25.0% | 8M+25.0% | 8M+25.0% |
Not reported in any period shown, so not listed: R&D Expenses.
QNME Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.7M-19.1% | $17.8M+78.9% | $24.3M+147.0% | $18.6M+72.4% | $14.4M+56.7% | $9.9M | $9.8M | $10.8M |
| Current Assets | $11.0M+7.2% | $17.0M+240.1% | $21.2M+378.0% | $15.0M+157.2% | $10.3M+190.4% | $5.0M | $4.4M | $5.8M |
| Cash & Equivalents | $670K-86.1% | $1.3M-13.3% | $1.6M+46.1% | $4.5M+65.7% | $4.8M+3797.1% | $1.5M+680.4% | $1.1M+229.7% | $2.7M+1232.6% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $197K+103.7% | $22K-89.8% | $124K+1103.9% | $132K | $97K | $216K | $10K | N/A |
| Accounts Receivable | $1.1M-19.2% | N/A | N/A | N/A | $1.4M-49.8% | N/A | N/A | $1.5M |
| Long-Term Investments | $0-100.0% | $0-100.0% | $16K0.0% | $16K | $16K0.0% | $16K | $16K | $0 |
| Total Liabilities | $4.6M-59.8% | $4.2M-54.6% | $12.1M+48.0% | $11.7M+62.4% | $11.6M+35.1% | $9.2M | $8.2M | $7.2M |
| Current Liabilities | $4.5M-53.6% | $4.0M-41.2% | $10.4M+89.9% | $9.8M+122.3% | $9.7M+64.0% | $6.8M | $5.5M | $4.4M |
| Non-Current Liabilities | $162K-91.5% | $178K-92.6% | $1.7M-37.3% | $1.8M-33.4% | $1.9M-28.8% | $2.4M | $2.7M | $2.8M |
| Long-Term Debt | N/A | N/A | $2.4M+211.2% | $2.4M+310.1% | $1.4M+54.0% | $774K | $785K | $590K |
| Total Equity | $7.0M+146.2% | $13.6M+1715.4% | $12.2M+639.8% | $7.0M+92.2% | $2.8M+344.8% | $750K+17.6% | $1.6M+163.4% | $3.6M+545.2% |
| Retained Earnings | -$14.8M-178.4% | -$8.1M-86.4% | -$8.3M-151.8% | -$6.7M-398.3% | -$5.3M-91245.1% | -$4.4M | -$3.3M | -$1.3M |
Not reported in any period shown, so not listed: Goodwill.
QNME Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$143K+91.5% | $1.4M+49.9% | -$453K+14.5% | -$4.0M-186.3% | -$1.7M-678.2% | $953K+1091.0% | -$530K-343.8% | -$1.4M-3575.9% |
| Depreciation & Amortization | $35K-12.7% | $35K-22.4% | $59K+44.3% | $56K+118.3% | $41K+55.3% | $45K+69.6% | $41K+62.5% | $26K+1.0% |
| Capital Expenditures | N/A | N/A | N/A | N/A | $10K | -$25K | $30K | $6K |
| Free Cash Flow | N/A | N/A | N/A | N/A | -$1.7M | $928K | -$561K | -$1.4M |
| Investing Cash Flow | N/A | N/A | -$7.0M-436.3% | -$109K-184.2% | $539K | $123K | -$1.3M | -$38K+51.4% |
| Financing Cash Flow | N/A | N/A | $4.4M+1662.7% | $3.7M-9.2% | $3.4M+2206.4% | $487K+1029.3% | $251K+404.9% | $4.0M+5958.1% |
| Share Buybacks | N/A | N/A | N/A | N/A | $214K | -$213K | -$74K | $880K |
Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid.
QNME Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | 73.8%-2.2pp | 27.2%+28.4pp | 18.2%+5.4pp | 21.0%-0.5pp | 76.0%+54.2pp | -1.2%-22.8pp | 12.8%-2.8pp |
| Operating Margin | N/A | -118.7% | -21.3%+34.3pp | -20.8%+11.7pp | -13.6%-7.0pp | -66.3%-67.2pp | -55.6%-57.2pp | -32.5%-24.5pp |
| Net Margin | N/A | 10.7% | -22.6%+31.6pp | -22.3%+10.5pp | -9.3%-9.3pp | -215.3% | -54.1%-55.5pp | -32.7%-25.4pp |
| Return on Equity | N/A | 1.1%+143.9pp | -13.0%+105.3pp | -19.5%+17.4pp | -31.4%-31.7pp | -142.8%-144.8pp | -118.3%-128.5pp | -36.9%+17.3pp |
| Return on Assets | N/A | 0.8%+11.6pp | -6.5%+13.3pp | -7.3%+5.1pp | -6.2%-6.2pp | -10.8% | -19.8% | -12.3% |
| Current Ratio | 2.46+1.4x | 4.27+3.5x | 2.03+1.2x | 1.52+0.2x | 1.06+0.5x | 0.74 | 0.81 | 1.32 |
| Debt-to-Equity | 0.66+0.2x | 0.31-0.7x | 0.20-0.3x | 0.35+0.2x | 0.48-0.9x | 1.03 | 0.48 | 0.16 |
| Asset Turnover | N/A | 0.070.0x | 0.29-0.1x | 0.33-0.1x | 0.67+0.1x | 0.05 | 0.37 | 0.38 |
| FCF Margin | N/A | N/A | N/A | N/A | -17.8% | 186.6% | -15.6% | -34.5% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Where Quanome Technologies, Inc. Ranks
Frequently Asked Questions
What is Quanome Technologies, Inc.'s annual revenue?
Quanome Technologies, Inc. (QNME) reported $5.9M in total revenue for fiscal year 2026. This represents a 111.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Quanome Technologies, Inc.'s revenue growing?
Quanome Technologies, Inc. (QNME) revenue grew by 111.8% year-over-year, from $2.8M to $5.9M in fiscal year 2026.
Is Quanome Technologies, Inc. profitable?
No, Quanome Technologies, Inc. (QNME) reported a net income of -$9.5M in fiscal year 2026.
What is Quanome Technologies, Inc.'s EBITDA?
Quanome Technologies, Inc. (QNME) had EBITDA of -$10.1M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Quanome Technologies, Inc.'s gross margin?
Quanome Technologies, Inc. (QNME) had a gross margin of 56.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Quanome Technologies, Inc.'s return on equity (ROE)?
Quanome Technologies, Inc. (QNME) has a return on equity of -135.4% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Quanome Technologies, Inc.'s free cash flow?
Quanome Technologies, Inc. (QNME) recorded an outflow of $3.2M in free cash flow during fiscal year 2026. This represents a -19.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Quanome Technologies, Inc.'s operating cash flow?
Quanome Technologies, Inc. (QNME) recorded an outflow of $3.2M in operating cash flow during fiscal year 2026, representing cash used by core business activities.
What are Quanome Technologies, Inc.'s total assets?
Quanome Technologies, Inc. (QNME) had $11.7M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Quanome Technologies, Inc.'s capital expenditures?
Quanome Technologies, Inc. (QNME) invested $2K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is Quanome Technologies, Inc.'s current ratio?
Quanome Technologies, Inc. (QNME) had a current ratio of 2.46 as of fiscal year 2026, which is generally considered healthy.
What is Quanome Technologies, Inc.'s debt-to-equity ratio?
Quanome Technologies, Inc. (QNME) had a debt-to-equity ratio of 0.66 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Quanome Technologies, Inc.'s return on assets (ROA)?
Quanome Technologies, Inc. (QNME) had a return on assets of -81.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Quanome Technologies, Inc.'s P/E ratio?
Quanome Technologies, Inc. (QNME) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $18.0M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Quanome Technologies, Inc.'s price-to-sales ratio?
Quanome Technologies, Inc. (QNME) trades at 3.1x sales, its market capitalization divided by revenue of $5.9M revenue, FY2026. The market capitalization is $18.0M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Quanome Technologies, Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2026, Quanome Technologies, Inc. (QNME) held $670K in cash, cash equivalents and investments, and reported an operating cash outflow of $3.2M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Quanome Technologies, Inc.'s Altman Z-Score?
Quanome Technologies, Inc. (QNME) has an Altman Z-Score of -1.17, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Quanome Technologies, Inc.'s Piotroski F-Score?
Quanome Technologies, Inc. (QNME) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Quanome Technologies, Inc.'s earnings high quality?
Quanome Technologies, Inc. (QNME) reported a net loss of $9.5M while operations used $3.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Quanome Technologies, Inc. cover its interest payments?
Quanome Technologies, Inc. (QNME) reported an operating loss of $10.2M against $150K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Quanome Technologies, Inc.?
Quanome Technologies, Inc. (QNME) scores 9 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.